64.20
Livanova Plc stock is traded at $64.20, with a volume of 56,148.
It is up +0.34% in the last 24 hours and up +1.55% over the past month.
UK-based LivaNova was born of a combination of Cyberonics in the US and Sorin in Italy. The medical-device firm is primarily focused on cardiopulmonary solutions (with heart-lung machines and oxygenation equipment) as well as neuromodulation devices for treatment-resistant epilepsy and depression. Following the merger, LivaNova divested its cardiac rhythm management, heart valve, and extracorporeal membrane oxygenation businesses. It derives roughly half of its revenue from the US market, another 21% from Europe, and the remainder from the rest of the world.
See More
Previous Close:
$64.12
Open:
$64.32
24h Volume:
56,148
Relative Volume:
0.10
Market Cap:
$3.51B
Revenue:
$1.28B
Net Income/Loss:
$-222.15M
P/E Ratio:
-15.70
EPS:
-4.09
Net Cash Flow:
$145.52M
1W Performance:
+4.57%
1M Performance:
+1.55%
6M Performance:
+41.16%
1Y Performance:
+36.81%
Livanova Plc Stock (LIVN) Company Profile
Name
Livanova Plc
Sector
Industry
Phone
4402033250662
Address
20 EASTBOURNE TERRACE, LONDON
Compare LIVN with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
LIVN
Livanova Plc
|
64.22 | 3.50B | 1.28B | -222.15M | 145.52M | -4.09 |
|
ABT
Abbott Laboratories
|
127.00 | 222.19B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
98.48 | 144.97B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
SYK
Stryker Corp
|
365.09 | 140.12B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
100.67 | 128.60B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
EW
Edwards Lifesciences Corp
|
84.86 | 49.82B | 5.88B | 1.34B | 799.60M | 2.3489 |
Livanova Plc Stock (LIVN) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-19-25 | Initiated | KeyBanc Capital Markets | Overweight |
| Oct-01-25 | Downgrade | Goldman | Buy → Neutral |
| May-20-25 | Upgrade | Wolfe Research | Peer Perform → Outperform |
| Feb-26-25 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| Oct-04-24 | Initiated | Goldman | Buy |
| Sep-17-24 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Mar-20-24 | Reiterated | Needham | Buy |
| Feb-20-24 | Upgrade | Mizuho | Neutral → Buy |
| Sep-06-23 | Initiated | HSBC Securities | Hold |
| Jul-19-23 | Initiated | Robert W. Baird | Neutral |
| Apr-14-23 | Initiated | Mizuho | Neutral |
| Dec-21-22 | Initiated | Barclays | Equal Weight |
| Apr-06-22 | Initiated | Wolfe Research | Outperform |
| Feb-24-22 | Upgrade | UBS | Neutral → Buy |
| Dec-03-21 | Initiated | Goldman | Buy |
| Aug-20-21 | Reiterated | Needham | Buy |
| Jul-20-21 | Upgrade | Needham | Hold → Buy |
| Mar-03-21 | Downgrade | Berenberg | Buy → Hold |
| Jan-05-21 | Downgrade | Needham | Buy → Hold |
| Sep-02-20 | Initiated | Robert W. Baird | Outperform |
| Jun-26-20 | Reiterated | Needham | Buy |
| Oct-30-19 | Reiterated | Needham | Buy |
| Feb-28-19 | Reiterated | Needham | Buy |
| Nov-28-18 | Initiated | UBS | Neutral |
| Aug-02-18 | Reiterated | Needham | Buy |
| Jun-08-18 | Initiated | Stifel | Buy |
| May-31-18 | Reiterated | Needham | Buy |
| Feb-28-18 | Reiterated | Needham | Buy |
View All
Livanova Plc Stock (LIVN) Latest News
What risks investors should watch in LivaNova PLC stockInsider Selling Patterns & Affordable Investment Strategies - bollywoodhelpline.com
2026 world cup analysis insights: Is LivaNova PLC stock a dividend growth opportunity2026 world cup usa national team third place match key players high defensive line winner prediction insights - Улправда
In-Line Blood Monitoring Devices Market is expected to reach US$ - openPR.com
Market Fear: What is the fair value of LivaNova PLC stock nowTrade Risk Assessment & Fast Entry Momentum Alerts - moha.gov.vn
Electroceutical Devices Market to Reach USD 29,785.39 million - openPR.com
Published on: 2026-01-02 09:16:46 - moha.gov.vn
Precision Trading with Livanova Plc (LIVN) Risk Zones - Stock Traders Daily
LivaNova stock tests investor patience as Wall Street weighs turnaround against volatility - AD HOC NEWS
LivaNova CEO talks growth roadmap as company targets sleep apnea, depression therapies - MassDevice
LIVANOVA PLC (LIVN) - MSN
LivaNova PLC $LIVN Shares Sold by Harbor Capital Advisors Inc. - MarketBeat
LivaNova plc diskutieren - sharewise.com
LivaNova PLC (LIVN) - MSN
Voya Investment Management LLC Sells 21,244 Shares of LivaNova PLC $LIVN - MarketBeat
Vagus Nerve Stimulators Market Industry Analysis 2025-2032 - openPR.com
Adult And Pediatric Hemoconcentrators Market 2025-2032: - openPR.com
LivaNova to present at JP Morgan Healthcare Conference in January - MSN
LivaNova to Present at J.P. Morgan Healthcare Conference in January 2026 - BioSpace
Is Optimism Around aura6000 and Margin Upside Altering The Investment Case For LivaNova (LIVN)? - Sahm
LivaNova to Present at J.P. Morgan Healthcare Conference in January - Lelezard
LivaNova (STU:LIA) EV-to-OCF : 12.43 (As of Dec. 22, 2025) - GuruFocus
LIVN (LivaNova) EV-to-OCF : 13.15 (As of Dec. 23, 2025) - GuruFocus
How LivaNova PLC stock trades during market volatilityJuly 2025 Breakouts & Short-Term Trading Alerts - Улправда
Avoiding Lag: Real-Time Signals in (LIVN) Movement - Stock Traders Daily
Why LivaNova PLC stock could outperform in 20252025 Year in Review & Fast Exit/Entry Strategy Plans - Улправда
Why LivaNova PLC stock is popular among millennials2025 Fundamental Recap & Risk Controlled Daily Plans - Улправда
LivaNova (NASDAQ:LIVN) Rating Increased to Strong-Buy at KeyCorp - MarketBeat
Is LivaNova PLC stock a dividend growth opportunity2025 Top Decliners & High Accuracy Investment Entry Signals - Улправда
LivaNova (NASDAQ:LIVN) Upgraded at Wall Street Zen - MarketBeat
Is LivaNova PLC (LIA) stock prepared for digital transitionEarnings Overview Summary & Safe Capital Growth Stock Tips - Улправда
Will LivaNova PLC (LIA) stock outperform value peersRate Cut & Precise Buy Zone Tips - Улправда
How interest rate cuts could boost LivaNova PLC stock2025 Biggest Moves & Long Hold Capital Preservation Tips - Улправда
LivaNova (FRA:LIA) EV-to-OCF : 12.26 (As of Dec. 19, 2025) - GuruFocus
LIVN: Analyst Initiates Coverage with Overweight Rating and $81 PT | LIVN Stock News - GuruFocus
KeyBanc Initiates LivaNova at Overweight With $81 Price Target - marketscreener.com
LIVN Stock: KeyBanc Initiates Coverage with Positive Outlook - GuruFocus
At US$62.08, Is It Time To Put LivaNova PLC (NASDAQ:LIVN) On Your Watch List? - Yahoo Finance
Is LivaNova PLC stock a top momentum play2025 Retail Activity & Step-by-Step Trade Execution Guides - DonanımHaber
KeyBanc initiates Livanova stock with Overweight rating, cites growth outlook By Investing.com - Investing.com Nigeria
How LivaNova PLC (LIA) stock valuation compares with sectorWeekly Gains Summary & Intraday High Probability Setup Alerts - Улправда
How buybacks impact LivaNova PLC stock valueEntry Point & Reliable Price Breakout Alerts - ulpravda.ru
[Form 4] LivaNova PLC Insider Trading Activity - Stock Titan
Fundamentals Check: Why LivaNova PLC stock could outperform in 2025Quarterly Performance Summary & Free Expert Verified Stock Movement Alerts - Улправда
Weekly Earnings: How LivaNova PLC (LIA) stock valuation compares with sectorWeekly Stock Summary & Pattern Based Trade Signal System - ulpravda.ru
Aug Analyst Calls: How buybacks impact LivaNova PLC stock valueWeekly Investment Recap & Community Driven Trade Alerts - Улправда
Mizuho Maintains LivaNova (LIVN) Outperform Recommendation - Nasdaq
Dir Podlogar Acquires 2,086 Of LivaNova PLC [LIVN] - TradingView — Track All Markets
LivaNova (NASDAQ:LIVN) Price Target Raised to $72.00 - MarketBeat
LIVN Analyst Rating: Mizuho Raises Price Target to $72.00 | LIVN Stock News - GuruFocus
Nomura Holdings Inc. Takes $3.92 Million Position in LivaNova PLC $LIVN - MarketBeat
Assessing LivaNova (LIVN)’s Valuation After Hiring ResMed Veteran to Lead Sleep Apnea Commercialization - Sahm
Livanova Plc Stock (LIVN) Financials Data
Revenue
Net Income
Cash Flow
EPS
Livanova Plc Stock (LIVN) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| PODLOGAR SUSAN M | Director |
Dec 15 '25 |
Option Exercise |
0.00 |
2,355 |
0 |
2,355 |
| Hutchinson Michael Damon | SVP, CLO and Company Secretary |
Dec 15 '25 |
Option Exercise |
0.00 |
2,254 |
0 |
7,920 |
| Story Brooke | Director |
Nov 18 '25 |
Sale |
53.94 |
250 |
13,485 |
6,232 |
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):